| Trial ID: | L5026 |
| Source ID: | NCT01515384
|
| Associated Drug: |
18f-Av-133
|
| Title: |
A Trial of 18F-AV-133 Positron Emission Tomography (PET)
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes|Type 2 Diabetes
|
| Interventions: |
DRUG: 18F-AV-133
|
| Outcome Measures: |
Primary: Pancreatic uptake and clearance of 18F-AV-133 tracer as determined by SUVR, SUVR=standard uptake value ratio, 0-90 minutes |
|
| Sponsor/Collaborators: |
Sponsor: Avid Radiopharmaceuticals
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
19
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2010-06
|
| Completion Date: |
2013-02
|
| Results First Posted: |
|
| Last Update Posted: |
2020-01-13
|
| Locations: |
Research Site, New York, New York, 10027, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01515384
|
